Loading
DuPont de Nemours, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 06 Aug 2021.
DuPont de Nemours, Inc.: what insiders have been doing
Headquartered in Wilmington, United States, DuPont de Nemours, Inc. belongs to the Chemicals & Materials sector and traces its origins to 1802. Filings by its managers are published through SEC (Form 4). Over the twelve months to 18 October 2026, 54 filings were filed, from 18 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Across the 5,458 companies tracked on its exchange, the median is 22 filings; at 54 filings, this issuer sits above that mark. Over the whole record (from 2021), the tally stands at 1 purchase and 12 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 6.85 bn USD and net income at -779.0 m USD; the dividend was 1.43 USD per share.
There has been no open-market purchase by an insider of DuPont de Nemours, Inc. for at least a year. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4.
For comparison within the same sector, see the insider buying recorded at Culp Inc and Gold.com, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
409
Thresholds
n/a
Buy Volume
€320,798
1 ops. · all time
Sell Volume
€3M
12 ops. · all time
Who traded when
BuySaleJon D. Kemp1 sale
Analyst consensus: bullish or bearish?
Analysts rate DuPont de Nemours, Inc. Buy (bullish), based on 17 analysts. Average price target: US$165.47.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 18,826 of 24,148 companies
32.4
score / 100
Value31
Quality34
FCF yld1.0%
Earn yld-4.4%
EV/EBITDA17.9x
ROE1.8%
Gross mgn35%
Net mgn-11%
Debt/EBITDA2.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$130.45
Analyst consensus
17 analystsBuy
US$145.00Target US$165.47(+27%)US$186.00
Income statement
RevenueUS$6.8B
Gross profitUS$2.4B35% margin
EBITDAUS$1.2B17% margin
Net income-US$779M0.8% margin
Valuation
PER (trailing)35.1x
PER (forward)16.3x
P/Book1.3x
Beta1.08
Balance sheet & cash
Market capUS$17.6B
Total debtUS$3.2B
Free Cash FlowUS$172M
Debt / Equity23%
Profitability & ownership
ROE1.8%
ROA2.1%
% insiders0.2%
% institutions80.0%
Last declaration on 1 September 2026
Declarations409 total
237.261 shares@ US$136.980.0002% mcap75.2% of flowCommon StockSEC:0001628280-26-059915:0
365.017 shares@ US$136.980.0003% mcap3.8% of flowCommon StockSEC:0001628280-26-059913:0
282.888 shares@ US$136.980.0002% mcap3.9% of flowCommon StockSEC:0001628280-26-059914:0
53,000 shares0Common StockSEC:0001628280-26-058089:0
34,485 shares0Common StockSEC:0001628280-26-058089:1
100.807 shares@ US$146.3750.0001% mcap100.0% of flowCommon StockSEC:0001628280-26-055312:0
373.778 shares@ US$146.3750.0003% mcap100.0% of flowCommon StockSEC:0001628280-26-055317:0
1,032.631 shares@ US$48.420.0003% mcap3.8% of flowCommon StockSEC:0001628280-26-039867:0
4,030 shares0Common StockSEC:0001628280-26-038885:0
4,030 shares0Common StockSEC:0001628280-26-038878:0
4,030 shares0Common StockSEC:0001628280-26-038879:0
4,030 shares0Common StockSEC:0001628280-26-038880:0
4,030 shares0Common StockSEC:0001628280-26-038881:0
4,030 shares0Common StockSEC:0001628280-26-038882:0
4,030 shares0Common StockSEC:0001628280-26-038883:0
4,030 shares0Common StockSEC:0001628280-26-038884:0
4,030 shares0Common StockSEC:0001628280-26-038886:0
216.493 shares@ US$50.0424.8% of flowCommon StockSEC:0001628280-26-013894:0
999.201 shares@ US$50.043.7% of flowCommon StockSEC:0001628280-26-013901:0
774.38 shares@ US$50.043.8% of flowCommon StockSEC:0001628280-26-013899:0
946 shares0Common StockSEC:0001628280-26-011210:0
11,903 shares0Common StockSEC:0001628280-26-011207:0
19,838 shares0Common StockSEC:0001628280-26-011201:0
9,919 shares0Common StockSEC:0001628280-26-011198:0
25 of 409 declarations
About DuPont de Nemours, Inc.
DuPont de Nemours, Inc. (NYSE: DD) is a U.S.-based industrial company headquartered in Wilmington, Delaware, United States, focused on advanced materials, specialty chemicals, and application-driven solutions for demanding end markets. Its corporate heritage traces back to 1802, giving the company one of the deepest industrial legacies in the sector. That long operating history, combined with a strong research-and-development culture, remains central to DuPont’s competitive positioning. The company highlights a global footprint of manufacturing sites, laboratories, technical centers, and innovation hubs across more than 70 countries, with major clusters in North America, Europe, and Asia. ([dupont.com](https://www.dupont.com/content/dupont/amer/us/en/corporate-homepage/about.html?utm_source=openai))
DuPont’s portfolio is built around high-value, performance-oriented technologies rather than commodity chemicals. Core offerings include water purification and treatment solutions such as membranes and ion-exchange resins, healthcare and medical packaging materials, automotive engineered materials, sustainable construction solutions, aerospace materials, printing and packaging technologies, and advanced materials used in electronics and semiconductor manufacturing. The company’s brands are typically differentiated by reliability, durability, process efficiency, and safety, which helps position DuPont as a strategic supplier to industrial customers rather than a mass-market materials producer. ([dupont.com](https://www.dupont.com/content/dupont/amer/us/en/corporate-homepage/about.html?utm_source=openai))
Read moreShow less
A major strategic theme in 2025 and 2026 has been portfolio transformation. DuPont completed the separation of its electronics business into Qnity and announced the planned divestiture of its Aramids business, signaling a clearer focus on higher-growth areas such as Water and Healthcare. Management has framed these actions as part of a broader effort to simplify the organization, sharpen capital allocation, and improve long-term value creation. Recent company communications also point to shareholder-return initiatives and continued portfolio optimization. ([dupont.com](https://www.dupont.com/news/dupont-announces-effectiveness-of-form-10-registration-statement-for-qnity.html?utm_source=openai))
For French-speaking investors in France, Belgium, and Switzerland, DuPont stands out as a quality cyclical name within the Chemicals & Materials universe. It offers exposure to long-term structural themes including clean water, healthcare, industrial efficiency, advanced electronics, and resilient infrastructure. At the same time, the investment case must be viewed through the lens of execution risk, restructuring complexity, historical liability exposure, and regulatory scrutiny. Listed on the NYSE under DD in the United States, DuPont remains a globally recognized reference in specialty materials rather than a basic-chemicals producer. ([investors.dupont.com](https://www.investors.dupont.com/news-and-media/press-release-details/2026/DuPont-Reports-Fourth-Quarter-and-Full-Year-2025-Results/default.aspx?utm_source=openai))
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
